NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 171 filers reported holding NEOGENOMICS INC in Q3 2018. The put-call ratio across all filers is 0.09 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $52,582 | -26.4% | 3,791 | -16.6% | 0.00% | -33.3% |
| Q1 2024 | $71,464 | -9.9% | 4,546 | -7.2% | 0.01% | -14.3% |
| Q4 2023 | $79,282 | +60.5% | 4,900 | +22.0% | 0.01% | +40.0% |
| Q3 2023 | $49,410 | -26.3% | 4,017 | -3.7% | 0.01% | -28.6% |
| Q2 2023 | $67,045 | -29.2% | 4,172 | -23.4% | 0.01% | -30.0% |
| Q1 2023 | $94,763 | +84.7% | 5,443 | -2.0% | 0.01% | +66.7% |
| Q4 2022 | $51,310 | +97.3% | 5,553 | +83.4% | 0.01% | +100.0% |
| Q3 2022 | $26,000 | +160.0% | 3,027 | +149.5% | 0.00% | +200.0% |
| Q2 2022 | $10,000 | -52.4% | 1,213 | -28.1% | 0.00% | -66.7% |
| Q1 2022 | $21,000 | -66.1% | 1,687 | -7.6% | 0.00% | -57.1% |
| Q4 2021 | $62,000 | +10.7% | 1,826 | +56.9% | 0.01% | -12.5% |
| Q3 2021 | $56,000 | +9.8% | 1,164 | +2.2% | 0.01% | +14.3% |
| Q2 2021 | $51,000 | -7.3% | 1,139 | +0.3% | 0.01% | -22.2% |
| Q1 2021 | $55,000 | -9.8% | 1,136 | 0.0% | 0.01% | -18.2% |
| Q4 2020 | $61,000 | +48.8% | 1,136 | +1.2% | 0.01% | +22.2% |
| Q3 2020 | $41,000 | +17.1% | 1,122 | 0.0% | 0.01% | +12.5% |
| Q2 2020 | $35,000 | +16.7% | 1,122 | +4.3% | 0.01% | +60.0% |
| Q1 2020 | $30,000 | 0.0% | 1,076 | +3.8% | 0.01% | +25.0% |
| Q4 2019 | $30,000 | +57.9% | 1,037 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $19,000 | -13.6% | 1,037 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $22,000 | +4.8% | 1,037 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $21,000 | +61.5% | 1,037 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $13,000 | -13.3% | 1,037 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $15,000 | +15.4% | 1,037 | 0.0% | 0.00% | -20.0% |
| Q2 2018 | $13,000 | +62.5% | 1,037 | 0.0% | 0.01% | +66.7% |
| Q1 2018 | $8,000 | -11.1% | 1,037 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $9,000 | -18.2% | 1,037 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $11,000 | +22.2% | 1,037 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $9,000 | +12.5% | 1,037 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $8,000 | 0.0% | 1,037 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $8,000 | 0.0% | 1,037 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $8,000 | 0.0% | 1,037 | 0.0% | 0.01% | -16.7% |
| Q2 2016 | $8,000 | +33.3% | 1,037 | 0.0% | 0.01% | +50.0% |
| Q1 2016 | $6,000 | – | 1,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,615,513 | $13,166,000 | 9.25% |
| First Light Asset Management, LLC | 2,715,487 | $22,131,000 | 2.58% |
| PERKINS CAPITAL MANAGEMENT INC | 202,550 | $1,651,000 | 1.71% |
| Greenhouse Funds LLLP | 1,395,035 | $11,370,000 | 1.25% |
| EMERALD ADVISERS, LLC | 1,213,353 | $9,889,000 | 0.51% |
| Bullseye Asset Management LLC | 108,272 | $883,000 | 0.50% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 959,858 | $7,823,000 | 0.45% |
| OAK FAMILY ADVISORS, LLC | 88,604 | $722,000 | 0.36% |
| MPM BioImpact LLC | 135,573 | $1,105,000 | 0.31% |
| Fernwood Investment Management, LLC | 70,285 | $573,000 | 0.25% |